| Item | 9m 2024 | 9m 2025 | Change |
|---|---|---|---|
| Revenues | 2,048.20 | 2,291.12 | 11.9 % |
| Gross Income | 534.28 | 534.00 | (0.1 %) |
| Operating Income | 286.83 | 232.72 | (18.9 %) |
| Net Income | 213.78 | 226.00 | 5.7 % |
| Average Shares | 232.00 | 232.00 | - |
| Earnings Per Share before unusual items (Riyals) | 0.92 | 0.97 | 5.7 % |
| EPS (Riyal) | 0.92 | 0.97 | 5.7 % |
Including minority interest, the company’s net profit declined 1.3% to SAR 192.63 million, compared with SAR 195.28 million in the same period last year.
Mature business profitability rose despite sector wage pressures and market competition. This occurred despite increased non-recurring receivables provisions and a margin reduction in the operate and manage contract.
Additionally, ramp-up losses at the newly opened Al Madinah hospital offset lower financing costs. Profit attributable to shareholders increased 5.7% to SAR 226 million, as minority shareholders absorbed ramp-up losses. EPS was SAR 0.98 (down 2.2% year-on-year).
Fakeeh Care’s Q3 net profit fell 24% to SAR 71.6 million, from SAR 93.6 million in Q3 2024, and sequentially dropped 12.8% from SAR 82.1 million in Q2 2025.
| Item | Q3 2024 | Q3 2025 | Change |
|---|---|---|---|
| Revenues | 713.82 | 778.26 | 9.0 % |
| Gross Income | 183.82 | 177.25 | (3.6 %) |
| Operating Income | 104.54 | 74.13 | (29.1 %) |
| Net Income | 93.59 | 71.60 | (23.5 %) |
| Average Shares | 232.00 | 232.00 | - |
| Earnings Per Share before unusual items (Riyal) | 0.40 | 0.31 | (23.5 %) |
| EPS (Riyal) | 0.40 | 0.31 | (23.5 %) |
| Item | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Revenues | 811.84 | 778.26 | (4.1 %) |
| Gross Income | 180.62 | 177.25 | (1.9 %) |
| Operating Income | 81.61 | 74.13 | (9.2 %) |
| Net Income | 82.12 | 71.60 | (12.8 %) |
| Average Shares | 232.00 | 232.00 | - |
| Earnings Per Share before unusual items (Riyal) | 0.35 | 0.31 | (12.8 %) |
| EPS (Riyal) | 0.35 | 0.31 | (12.8 %) |
| Company | Estimated | Actual | Change |
|---|---|---|---|
| SHAKER | 21.30 | 17.82 | |
| GAS | 35.00 | 38.15 | |
| BURGERIZZR | 1.30 | 3.65 | |
| BUDGET SAUDI | 86.54 | 80.27 | |
| AVALON PHARMA | 11.67 | 8.28 | |
| FAKEEH CARE | 65.90 | 71.60 | |
| SAVOLA GROUP | 122.00 | 385.56 | |
| ALMUNAJEM | 30.60 | 31.70 | |
| UACC | 11.70 | 11.81 | |
| MARAFIQ | 132.00 | 170.67 |
| Company | Estimated | Actual | Change |
|---|---|---|---|
| SHAKER | 21.30 | 17.82 | |
| GAS | 35.00 | 38.15 | |
| BURGERIZZR | 1.30 | 3.65 | |
| BUDGET SAUDI | 86.54 | 80.27 | |
| AVALON PHARMA | 11.67 | 8.28 | |
| FAKEEH CARE | 65.90 | 71.60 | |
| SAVOLA GROUP | 122.00 | 129.96 | |
| ALMUNAJEM | 30.60 | 31.70 | |
| UACC | 11.70 | 11.81 | |
| MARAFIQ | 132.00 | 170.67 |
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website

Comments Analysis: